openPR Logo
Press release

Rising Diabetes Prevalence Driving Growth In The Market Due To Increasing Risk Of Nerve Compression: A Significant Driver Propelling The Nerve Entrapment Syndrome Market In 2025

04-25-2025 08:43 AM CET | Health & Medicine

Press release from: The Business Research Company

Nerve Entrapment Syndrome

Nerve Entrapment Syndrome

The Nerve Entrapment Syndrome Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Nerve Entrapment Syndrome Market Size and Projected Growth Rate?
In recent times, we've witnessed substantial growth in the market size for nerve entrapment syndrome. It is anticipated to surge from $4.03 billion in 2024 to $4.34 billion in 2025, representing a compound annual growth rate (CAGR) of 7.8%. The drivers for growth during the historic period include a rise in incidents of peripheral neuropathy, a surge in diabetes cases, an expanding elderly population, an increase in obesity rates, and a surge in chronic disease prevalence.

In the ensuing years, the market for nerve entrapment syndrome is anticipated to observe robust growth, escalating to $5.77 billion by 2029 with a CAGR of 7.4%. This projected growth within the forecast duration may be attributed to factors including a rising elderly population, an increase in worldwide instances of peripheral nerve injuries, expansion of government initiatives and reimbursement policies, a surge in traumatic injuries cases, and a growing demographic of diabetic patients. Some of the noteworthy trends for the forecast period encompass advancements in research and development to broaden product offerings, progression in minimally invasive surgical procedures, growth in the field of regenerative medicine, improvements in imaging techniques, innovative physical therapy and rehabilitation practices, and continuance of genetic research and personalized medicine.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22069

What Are the Major Segments in the Nerve Entrapment Syndrome Market?
The nerve entrapment syndrome market covered in this report is segmented -

1) By Type: Carpal Tunnel Syndrome, Cubital Tunnel Syndrome, Tarsal Tunnel Syndrome, Meralgia Parasthetica, Other Types
2) By Treatment Modality: Medications, Physical Therapy, Interventional Procedures, Alteative Therapies
3) By Administration Route: Oral Administration, Injectable Administration, Topical Administration
4) By Severity Of Condition: Mild, Moderate, Severe, Post-Surgical Complications

Subsegments:
1) By Carpal Tunnel Syndrome (CTS): Idiopathic Carpal Tunnel Syndrome, Work-Related/Repetitive Strain CTS, Diabetic Neuropathy-Associated CTS, Traumatic or Post-Surgical CTS, Pregnancy-Induced CTS
2) By Cubital Tunnel Syndrome: Idiopathic Cubital Tunnel Syndrome, Repetitive Motion-Induced Cubital Tunnel Syndrome, Post-Traumatic/Ulnar Nerve Injury-Related Cubital Tunnel Syndrome, Osteoarthritis-Related Cubital Tunnel Syndrome, Post-Surgical Cubital Tunnel Syndrome
3) By Tarsal Tunnel Syndrome (TTS): Idiopathic Tarsal Tunnel Syndrome, Trauma-Induced Tarsal Tunnel Syndrome, Diabetes-Associated Tarsal Tunnel Syndrome, Flatfoot-Related Tarsal Tunnel Syndrome, Post-Surgical Or Scar Tissue-Related TTS
4) By Meralgia Paresthetica (MP): Idiopathic Meralgia Paresthetica, Obesity-Associated Meralgia Paresthetica, Pregnancy-Related Meralgia Paresthetica, Post-Surgical Or Scar-Induced Meralgia Paresthetica, Diabetic Neuropathy-Related Meralgia Paresthetica
5) By Other Types: Radial Tunnel Syndrome, Thoracic Outlet Syndrome, Peroneal Nerve Entrapment, Sciatic Nerve Entrapment, Brachial Plexus Compression Syndromes

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22069&type=smp

What Are The Driving Nerve Entrapment Syndrome Market Evolution?
The anticipated surge in the nerve entrapment syndrome market is likely to be driven by the escalating diabetic patient demographic. These individuals struggle with chronic conditions that impede effective blood sugar management due to insufficient or inefficient insulin production. The burgeoning diabetic population, which stems from obesity and sedentary lifestyle tendencies, is sparking a rise in type 2 diabetes. This rise heightens the risk of nerve entrapment syndrome as diabetic nerve damage potentially weakens nerves and associated structures, rendering them susceptible to compression. As a case in point, in June 2024, the National Health Service in the UK reported over half a million (549,000) individuals at potential risk for developing type 2 diabetes in 2023, bringing the sum of people afflicted with non-diabetic hyperglycemia, also known as pre-diabetes, to 3,615,330. Indicating an almost 20% increase compared to 3,065,825 subjects in 2022. Thus, the flourishing diabetic patient pool fuels the growth of the nerve entrapment syndrome market. The nerve entrapment syndrome market is predicted to be propelled further by the expanding obese population. These individuals bear a body mass index (BMI) of over 30, implying a distinctly high body fat percentage considered unhealthy for most. The climbing obese population, spurred by unsound dietary practices, sedentary lifestyles, and environmental influences towards unhealthy eating habits, faces increased chances of nerve entrapment syndrome as excess weight applies greater pressure on nerves. For example, the Office for Health Improvement and Disparities (OHID), a DHSC's branch in the UK, revealed that around 26.2% of adults were grappling with obesity in 2022-2023, marking an increase from 25.9% the previous year. Therefore, the swelling obese demographic is catalyzing the nerve entrapment syndrome market's growth.

Which Firms Dominate The Nerve Entrapment Syndrome Market Segments?
Major companies operating in the nerve entrapment syndrome market are Pfizer Inc., Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Athletico Physical Therapy, Hinge Health, Kessler Rehabilitation Center, SPR Therapeutics, Centaur Pharmaceuticals, ProActive Physical Therapy & Rehabilitation, Care24 Pvt Ltd., Grünenthal GmbH, Total Performance Physical Therapy, Back 2 Health, Cornerstone Physical Therapy, OrthoSport Physical Therapy & Rehabilitation, Physio Tattva, InvaGen Pharmaceuticals Inc., WEX Pharmaceuticals Inc., Dogwood Therapeutics Inc., Endo Spine Clinic

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/nerve-entrapment-syndrome-global-market-report

Which Is The Largest Region In The Nerve Entrapment Syndrome Market?
North America was the largest region in the nerve entrapment syndrome market in 2024. The regions covered in the nerve entrapment syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Nerve Entrapment Syndrome Market?
2. What is the CAGR expected in the Nerve Entrapment Syndrome Market?
3. What Are the Key Innovations Transforming the Nerve Entrapment Syndrome Industry?
4. Which Region Is Leading the Nerve Entrapment Syndrome Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Diabetes Prevalence Driving Growth In The Market Due To Increasing Risk Of Nerve Compression: A Significant Driver Propelling The Nerve Entrapment Syndrome Market In 2025 here

News-ID: 3987498 • Views:

More Releases from The Business Research Company

Emerging Trends to Reshape the Surgical Energy Instruments Market: Innovative Technologies In Surgical Energy Instruments as a Key Influencer
Emerging Trends to Reshape the Surgical Energy Instruments Market: Innovative Te …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Surgical Energy Instruments Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In the past few years, the market size of surgical energy instruments has seen substantial growth. The market which is projected to be worth $4.68 billion in 2024, is expected to inflate to $5.2
2025-2034 Spatial omics Market Evolution: Disruptions, Innovations, and Untapped Opportunities
2025-2034 Spatial omics Market Evolution: Disruptions, Innovations, and Untapped …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Spatial omics Market Through 2025? In recent years, the size of the spatial omics market has seen rapid expansion. The estimations show an increase to $0.33 billion in 2025 from $0.3 billion in 2024, marking a compound annual growth rate (CAGR) of
Global Sigmoidoscope Market Projected to Grow at 6.1% CAGR, Reaching $3.38 Billion by 2029
Global Sigmoidoscope Market Projected to Grow at 6.1% CAGR, Reaching $3.38 Billi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Sigmoidoscope Industry Market Size Be by 2025? In recent years, there has been a significant increase in the size of the sigmoidoscope market. The market is projected to expand from $2.53 billion in 2024 to $2.67 billion in 2025, demonstrating a compound annual growth rate (CAGR)
2025-2034 Refurbished MRI Systems Market Roadmap: Insights for Competitive Advantage
2025-2034 Refurbished MRI Systems Market Roadmap: Insights for Competitive Advan …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Refurbished MRI Systems Market Size By 2025? The market size for refurbished MRI systems has experienced robust growth in the past few years. It is expected to rise from $0.77 billion in 2024 to $0.85 billion in 2025, showcasing a compound annual growth rate (CAGR)

All 5 Releases


More Releases for Syndrome

"Understanding Rett Syndrome: Trends and Advances in the Rett Syndrome Market"
The Rett Syndrome Market, valued at USD 225.02 million in 2022, is anticipated to surge to USD 515.06 million by 2029, reflecting a significant Compound Annual Growth Rate (CAGR) of 10.23% from 2023 to 2029. Overview of the Rett Syndrome Market: Rett syndrome, a rare genetic neurological and developmental disorder primarily impacting females, hinders brain development and causes progressive loss of motor skills and language. The market report underscores technological advancements
MISME Syndrome Market - Navigating Challenges, Embracing Abilities: MISME Syndro …
Newark, New Castle, USA: The "MISME Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. MISME Syndrome Market: https://www.growthplusreports.com/report/misme-syndrome-market/8883 This latest report researches the industry structure, sales, revenue,
Felty Syndrome Market - A Dedicated Approach to Felty Syndrome Care and Empowerm …
Newark, New Castle, USA: The "Felty Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Felty Syndrome Market: https://www.growthplusreports.com/report/felty-syndrome-market/8440 This latest report researches the industry structure, sales, revenue,
MISME Syndrome Market - Transforming Lives: Empowering Recovery from MISME Syndr …
Newark, New Castle, USA - new report, titled MISME Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the MISME Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global MISME Syndrome market. The report offers an overview of the market, which
Hepatorenal Syndrome Market - Reimagining Wellness, Redefining Survival: Hepator …
Newark, New Castle, USA - new report, titled Hepatorenal Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Hepatorenal Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Hepatorenal Syndrome market. The report offers an overview of the market, which
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syn …
Global Markets Directs, Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2016, provides an overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and